Beckman Coulter Life Sciences combines its particle characterization business with the Hach Company particle counting business.
Beckman Coulter Life Sciences, a Danaher Corporation-owned life science company, is combining its particle characterization business with the particle counting business from Hach Company, another Danaher company. The move brings together Beckman Coulter’s knowledge in cell viability, particle sizing, and particle analysis with Hach’s experience in air and liquid particle counting, according to a Beckman Coulter press statement.
In some countries, the transition is subject to completing consultation and/or information with certain employee representative bodies. Personnel from the particle counting business of Hach will transition into the Beckman Coulter Life Sciences business to work with the Beckman Coulter particle characterization team.
Source: Beckman Coulter Life Sciences
Texas' MD Anderson Cancer Center Creates New Cell Therapy Institute
November 11th 2024With the launch of the Institute for Cell Therapy Discovery and Innovation, the MD Anderson Cancer Center will bring together expertise in developing cell therapies for cancer, autoimmune diseases, and infections.